Immix Biopharma | Investor Presentation Deck | 60 slides · page 28 of 60
Includes a comparison table of clinical outcomes (ORR/CR/sCR) between NXC-201 and competitors.
Pitch deck · why_now · argue_timing · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
chart 1/1 disclaimer 1/1 list 2/2 table 1/1 title 3/3
Components 8
bar-vertical disclaimer bullet numbered data headline headline headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1